Emerging Markets Regulatory Tracker: Brazil, China, Russia (Vol. 1 No. 6)
This article was originally published in PharmAsia News
Executive Summary
The Emerging Markets Regulatory Tracker is a periodic PharmAsia News feature that summarizes and links to important regulatory developments impacting the biopharma and medical device industries in the Asia Pacific region and other emerging markets. The most recent issue appeared in PharmAsia News, April 18, 2011. The Emerging Markets Regulatory Tracker is prepared for PharmAsia News by RegLink Associates LLC.
|
The Emerging Markets Regulatory Tracker is a periodic PharmAsia News feature that summarizes and links to important regulatory developments impacting the biopharma and medical device industries in the Asia Pacific region and other emerging markets. The most recent issue appeared in (Also see "Emerging Markets Regulatory Tracker: Australia, Brazil, China, India, Korea (Vol. 1 No. 4)" - Scrip, 18 Apr, 2011.). The Emerging Markets Regulatory Tracker is prepared for PharmAsia News by RegLink Associates LLC. Brazil Convenes International Workshop on Good Laboratory Practices Brazil has opened public consultations aimed at establishing the first regulatory framework for analytical laboratories in the country. Brazil's regulator, ANVISA recently convened an international workshop that provided an opportunity to gather the experience of other countries to assist in the ongoing regulatory consultations. Representatives from regulatory agencies in the European Community (EDQM), Switzerland (FDPH) and the U.S. (FDA) participated as speakers and panelists at the workshop. Each of the participants provided case studies of what prompted the move to regulation in their countries. China 's State FDA Recognizes Local Achievements During 2006-2010 China's State FDA published a recognition of the 62 food and drug administration departments at all levels in China, such as the Beijing Drug Administration and Shanghai FDA, that have since 2006 conscientiously implemented the CPC Central Committee and State Council "Fifth" Planning and National People's Congress resolution. Those recognized have made outstanding contributions to promote and further mobilize food and drug regulatory work in China, according to SFDA. Russia Notes Imported Product Prices, Posts Most Complaints Products List And 2011 Action Plan The Russian agency Roszdravnadzor has made information available about medical products manufactured and imported into Russia and their selling prices with the introduction of data into the Roszdravnadzor automated system. The agency has also posted a list of companies whose drug products have received the most complaints in the first quarter of 2011 as well as its 2011 Action Plan. RegLink Associates publishes global updates on drug, biologic and medical device regulatory, policy, and health technology assessment to save companies time that would otherwise be spent finding, monitoring, and translating developments on websites worldwide. |